Analysts expect Starling Oncology, Inc. to report revenue of 172.68 M for Q3 26, against a range of 167.00 M to 178.37 M. The most recent reported quarter, Q2 26, came in at 161.28 M, a 1.7% miss against the 163.99 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 100.27 M | 104.41 M | 119.80 M | 136.56 M | 141.96 M | 147.44 M | 161.28 M | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 118.20 M | - | 127.24 M | 135.20 M | 152.25 M | 143.53 M | 171.64 M | 178.37 M | 208.42 M | 202.95 M | 213.14 M | 244.46 M | 260.66 M | 247.24 M | 275.86 M | ||||||
| Low Estimate | 109.20 M | - | 111.86 M | 122.06 M | 134.80 M | 134.52 M | 156.33 M | 167.00 M | 175.32 M | 175.52 M | 186.88 M | 213.09 M | 222.88 M | 228.75 M | 251.81 M | ||||||
| Consensus Estimate | 113.70 M | - | 119.55 M | 128.63 M | 143.53 M | 139.03 M | 163.99 M | 172.68 M | 191.87 M | 189.23 M | 200.01 M | 228.78 M | 241.77 M | 238.00 M | 263.84 M |
Analysts expect Starling Oncology, Inc. to report earnings per share of -0.05 for Q3 26, against a range of -0.05 to -0.05. The most recent reported quarter, Q2 26, came in at -0.08, a 33.3% miss against the -0.06 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.18 | -0.14 | -0.21 | -0.15 | -0.14 | -0.06 | -0.02 | -0.08 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | -0.06 | -0.07 | - | -0.12 | -0.11 | -0.09 | -0.09 | -0.05 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | 0.05 | 0.00 | 0.00 | ||||||
| Low Estimate | -0.08 | -0.09 | - | -0.12 | -0.11 | -0.09 | -0.11 | -0.07 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | 0.05 | 0.00 | 0.00 | ||||||
| Consensus Estimate | -0.07 | -0.08 | - | -0.12 | -0.11 | -0.09 | -0.10 | -0.06 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | 0.05 | 0.00 | 0.00 |
Pull Wall Street consensus for Starling Oncology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=STLN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "STLN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=STLN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();